{"product_id":"cardio-oncology-practice-manual-a-companion-to-braunwald-s-heart-disease-paperback-9780323681353","title":"Cardio-Oncology Practice Manual: A Companion to Braunwald’s Heart Disease (Paperback \/ softback) 9780323681353","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eCardio-Oncology Practice Manual: A Companion to Braunwald’s Heart Disease\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eComprehensive, portable coverage of cardio-oncology from the name you trust\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eJoerg Herrmann (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323681353, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 11 March 2022\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e544 pages\u003cbr\u003e23.5 x 19 x 3.4 cm, 1.09 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003e\"Overall, the book provides a succinct blueprint for the field of cardio-oncology. It informs its readers of the ideology necessary to provide quality clinical care in this specific area of medicine and shapes the direction that the field of cardio-oncology will likely take as its importance continues to increase over the coming years.\"\u003c\/i\u003e \u003c\/p\u003e \u003cp\u003e©Doody’s Review Service, 2022, Joseph T Hale, MD MPH Candidate (East Tennessee State University Quillen College of Medicine) \u003cb\u003eDoody's Score: 4 Stars!\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eToday’s patients have unique cardiologic needs before, during, and after cancer treatment. Chemotherapies, radiation therapy, and targeted therapies can produce acute side effects or lasting adverse consequences on the heart and circulatory system, making the field of cardio-oncology increasingly important in effective patient care. \u003ci\u003eCardio-Oncology Practice Manual\u003c\/i\u003e is a \u003cb\u003ecomprehensive, portable guide that provides practical approaches to assessment and management\u003c\/b\u003e of cardiovascular diseases due to the effects of cardiotoxic agents and treatments. Part of the Braunwald family of renowned cardiology references, it \u003cb\u003eclearly presents clinically relevant aspects of this growing field\u003c\/b\u003e in one quick, practical reference for a wide range of cardio-oncology providers. \u003c\/p\u003e\n\u003cul\u003e\n\u003cb\u003e \u003cli\u003eCovers all major cancer therapies, cardiovascular toxicities, and malignancies in a portable, authoritative guide\u003c\/li\u003e\u003c\/b\u003e—ideal for cardiologists, cardio-oncologists, general practitioners, internists, medical oncologists, and hematologists.  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eOffers \u003cb\u003etemplated and streamlined content\u003c\/b\u003e for quick retrieval, with key point summaries for each major section.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ePresents cardiac disease entities and specific malignant diseases in a \u003cb\u003esuccinct overview\u003c\/b\u003e format addressing important clinical care aspects.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFeatures \u003cb\u003e\"Central Illustrations\" for each topic\u003c\/b\u003e that visually summarize the chapter and its specific content including algorithms for management of cardiovascular toxicities and one-view overviews of malignancies.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eIncludes a \u003cb\u003ecomprehensive drug guide\u003c\/b\u003e that provides quick reference to drugs prescribed for cancers with therapeutic indications, manifestations and mechanisms of cardiotoxicity, their risk factors, and risk reduction strategies.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eBrings you up to date with \u003cb\u003enew immune therapies\u003c\/b\u003e, including immune checkpoint inhibitors and CAR T-cell therapies \u003c\/li\u003e \u003cb\u003e  \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eEnhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.\u003c\/li\u003e \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e1. The Cardio-Oncology Clinic\u003c\/p\u003e \u003cp\u003ePart I. Cardiovascular Disease Management Before Cancer Treatment\u003c\/p\u003e \u003cp\u003eSection A. The A-to-Z Before Therapy\u003c\/p\u003e \u003cp\u003e2. Key Points of Cardio-Oncology Evaluation Before Cancer Therapy\u003c\/p\u003e \u003cp\u003e3. Chemotherapeutic Risks Before Cancer Therapy\u003c\/p\u003e \u003cp\u003e4. Radiation Therapy Risks Before Cancer Therapy\u003c\/p\u003e \u003cp\u003e5. Bone Marrow Transplantation Risks Before Cancer Therapy\u003c\/p\u003e \u003cp\u003e6. Surgical Risks Before Cancer Therapy\u003c\/p\u003e \u003cp\u003eSection B. Cardiovascular Disease Prevention in Cancer Patients\u003c\/p\u003e \u003cp\u003e7. Cardiomyopathy\/Heart Failure Prevention Before Cancer Therapy\u003c\/p\u003e \u003cp\u003e8. Vascular Disease Prevention Before Cancer Therapy\u003c\/p\u003e \u003cp\u003e9. Thromboembolic Disease Prevention Before Cancer Therapy\u003c\/p\u003e \u003cp\u003e10. Arrhythmia Prevention and Device Management Before Cancer Therapy\u003c\/p\u003e \u003cp\u003e11. Hypertension and Renal Disease Prevention Before Cancer Therapy\u003c\/p\u003e \u003cp\u003e12. Pulmonary Disease Prevention Before Cancer Therapy\u003c\/p\u003e \u003cp\u003e13. Cardiopulmonary Exercise for Prevention Before Cancer Therapy\u003c\/p\u003e \u003cp\u003ePart II. Cardiovascular Disease Management During Cancer Treatment\u003c\/p\u003e \u003cp\u003eSection C. The A-to-Z Through Therapy\u003c\/p\u003e \u003cp\u003e14. Key Points of Cardio-Oncology Evaluation During Cancer Therapy\u003c\/p\u003e \u003cp\u003e15. Cardiomyopathy\/Heart Failure Myocarditis, and Takotsubo's During Cancer Therapy\u003c\/p\u003e \u003cp\u003e16. Structural Heart Disease\u003c\/p\u003e \u003cp\u003e17. Vascular Disease\u003c\/p\u003e \u003cp\u003e18. Thromboembolic Disease\u003c\/p\u003e \u003cp\u003e19. Arrhythmia, QTc Prolongation, and Device Management\u003c\/p\u003e \u003cp\u003e20. Hypertension and Renal Disease\u003c\/p\u003e \u003cp\u003e21. Pulmonary Disease\u003c\/p\u003e \u003cp\u003e22. Cardiovascular Imaging\u003c\/p\u003e \u003cp\u003ePart III. Cardiovascular Disease Management After Cancer Treatment\u003c\/p\u003e \u003cp\u003eSection D. The A-to-Z After Therapy\u003c\/p\u003e \u003cp\u003e23. Key Points of Cardio-Oncology Evaluation After Cancer Therapy\u003c\/p\u003e \u003cp\u003e24. Cancer Survivorship and Co-Morbidity Disease Risk\u003c\/p\u003e \u003cp\u003e25. Long-Term Complications of Chemotherapy\u003c\/p\u003e \u003cp\u003e26. Long-Term Complications of Radiation Therapy\u003c\/p\u003e \u003cp\u003eSection E. Cardiovascular Disease in Cancer Survivors\u003c\/p\u003e \u003cp\u003e27. Cardiomyopathy\/Heart Failure Prevention and Management\u003c\/p\u003e \u003cp\u003e28. Structureal Heart Disease Prevention and Management\u003c\/p\u003e \u003cp\u003e29. Vascular Disease Prevention and Management\u003c\/p\u003e \u003cp\u003e30. Thromboembolic Disease Prevention and Manageent\u003c\/p\u003e \u003cp\u003e31. Arrhythmia Prevention and Management\u003c\/p\u003e \u003cp\u003e32. Hypertension and Renal Failure Prevention and Management\u003c\/p\u003e \u003cp\u003e33. Pulmonary Disease Prevention and Management\u003c\/p\u003e \u003cp\u003e34. Cardiopulmonary Rehabilitation\u003c\/p\u003e \u003cp\u003eSection F. Cardiovascular Disease Management in Specific Malignant Diseases\u003c\/p\u003e \u003cp\u003e35. Breast Cancer\u003c\/p\u003e \u003cp\u003e36. Uterine, Ovary, and Cervical Cancer\u003c\/p\u003e \u003cp\u003e37. Prostate and Testicular Cancer\u003c\/p\u003e \u003cp\u003e38. Renal and Urinary Bladder Cancer\u003c\/p\u003e \u003cp\u003e39. Lung Cancer\u003c\/p\u003e \u003cp\u003e40. Colorectal Cancer\u003c\/p\u003e \u003cp\u003e41. Esophageal and Gastric Cancer\u003c\/p\u003e \u003cp\u003e42. Hepatobiliary Carcinomas\u003c\/p\u003e \u003cp\u003e43. Pancreatic Cancer\u003c\/p\u003e \u003cp\u003e44. Melanoma\u003c\/p\u003e \u003cp\u003e45. Head-and-Neck Cancers\u003c\/p\u003e \u003cp\u003e46. Thyroid cancer\u003c\/p\u003e \u003cp\u003e47. Glioblastoma\u003c\/p\u003e \u003cp\u003e48. Bone and Soft Tissue Sarcomas\u003c\/p\u003e \u003cp\u003e49. Leukemias\u003c\/p\u003e \u003cp\u003e50. Lymphomas\u003c\/p\u003e \u003cp\u003e51. Multiple Myeloma and Cardiac Amyloidosis\u003c\/p\u003e \u003cp\u003e52. Carcinoid\u003c\/p\u003e \u003cp\u003e53. Cardiac Masses\u003c\/p\u003e \u003cp\u003ePart IV. Cancer Drugs\u003c\/p\u003e \u003cp\u003e54. Cancer Therapeutic Drug Guide\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46650450608408,"sku":"9780323681353","price":79.59,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323681353_03a71b97-699f-46e8-9a47-a757d507e695.jpg?v=1694990102","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/cardio-oncology-practice-manual-a-companion-to-braunwald-s-heart-disease-paperback-9780323681353","provider":"Freshly Printed Books","version":"1.0","type":"link"}